Dan Norton Associate Director, Product Management Personalis Earns Top Spot in The Scientist’s Top 10 Innovations of 2022 On December 12, Personalis announced that its personalized cancer assay, NeXT Personal®, earned the top spot on The Scientist’s Top 10 Innovations of 2022 list, which highlights instruments, assays, technologies, and [...]
Dan Norton Associate Director, Product Management Personalis, Inc. Understanding and Evaluating the Latest Advances in Liquid Biopsy Technology Liquid biopsies are a hot topic in oncology, and for good reason. Some tout them as a relatively painless alternative to operations that can be difficult, expensive, and extremely uncomfortable. While others [...]
Dan Norton Associate Director, Product Management Personalis, Inc. Whole-genome sequencing approach for cancer validated by Cambridge study One of the most interesting aspects of precision medicine is that in order to treat each person’s disease individually, we have to understand how the disease looks across a population. In other words, [...]
